抑制GADD45A有助于心脏重塑,通过促进炎症,纤维化和缩
Adel Rostami1,2,3,4, Xavier Palomer5,6,7,8, Javier Pizarro-Delgado1,2,3,4
1Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, 08028, España.
Cellular and molecular life sciences : CMLS
|April 29, 2025
概括
增长停止和诱导DNA损伤的45A (GADD45A) 蛋白质保护心脏免受纤维化,炎症和亡. 缺乏GADD45A会使心脏缩和功能恶化,这表明有治疗潜力.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 细胞应激反应的应激反应
背景情况:
- 诱导增长停止和DNA损伤的45A (GADD45A) 参与细胞应激反应.
- 它在心脏病中的作用在很大程度上仍未被探索.
- 在其他器官中,GADD45A已经证明了对其他器官的炎症和纤维化的保护功能.
研究的目的:
- 为了研究GADD45A在心脏中的功能.
- 为了确定GADD45A缺乏对心脏结构和功能的影响.
- 探索GADD45A在心脏炎症和纤维化中的作用.
主要方法:
- 使用了具有构成性和系统性缺失的GADD45A淘汰赛小鼠.
- 检查了来自人类的心脏细胞 (AC16心肌细胞).
- 评估了心脏纤维化,炎症,亡,增大和功能.
主要成果:
- 在淘汰赛小鼠中,Gadd45a抑制导致心脏纤维化,炎症和亡.
- 这些变化与AP-1,NF-κB和STAT3.3的活性增加有关.
- Gadd45a删除导致显著的心脏缩,损害心脏形态和功能.
- 人类心肌细胞中的GADD45A过度表达减少了TNF-α诱导的炎症和纤维性反应.
结论:
- GADD45A在心脏中起着至关重要的保护作用.
- 它可以预防心脏炎症,纤维化和亡,从而保持心脏功能.
- 向GADD45A可能为心脏缩和心力衰竭提供治疗策略.
相关概念视频
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Imbalances in Cardiac Output
1.2K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
302
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
302
Pathophysiology of Cardiac Performance
479
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
479
G-Protein Gated Ion Channels
4.4K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.4K


